Clinical Trials Logo

Filter by:
NCT ID: NCT05668195 Recruiting - ADHD Clinical Trials

Systematic Aerobics and Intelligent Monitoring System in Executive Skill Training for School-aged Children With ADHD

Start date: May 24, 2022
Phase: N/A
Study type: Interventional

Around 7.2% of children around the world are suffering from Attention Deficit Hyperactivity Disorder (ADHD). Systematic executive skill training for children is currently recognized as one of the main programs for psychosocial behavioral interventions in ADHD, but the theoretical basis for the 1 hour "play class" component of the 3 hours per week children's classroom is insufficient. We have developed a closed-loop moderate-intensity aerobic training system, which is combined with an intelligent monitoring system, to further standardize and improve the treatment and management of ADHD intervention. The intelligent monitoring system in this study includes physiological intelligent monitoring (heart rate data) and psychological and behavioral intelligent monitoring (based on the computerized "adaptive" executive function testing procedures and clinical questionnaire scale). 200 subjects aged 6-12 years with a diagnosis of ADHD based on the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria are randomly assigned into two groups to receive executive skill training and systematic aerobic exercise and intelligent monitoring system, or systematic executive skill training for 13 weeks. Symptoms severity is assessed by Vanderbilt Assessment Scales at weeks 0, 6, and 13. Subjects' executive function is assessed using executive function tests before and after training, parental depression/anxiety assessment, family environment assessment, and monitoring of heart rate during exercise are also included. All the other sociodemographic data are assessed. This study will investigate the effects of systematic aerobic exercise and intelligent monitoring system in executive skill training on the promotion of cold executive functions such as responsiveness, flexibility, and inhibition and hot executive functions such as reward mechanisms in children, and their effects on children with ADHD and their families.

NCT ID: NCT05667961 Recruiting - Schizophrenia Clinical Trials

Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug Discontinuation

Start date: September 15, 2022
Phase:
Study type: Observational

Study objectives: 1. Describe the characteristics of discharged patients with schizophrenia achieving functional remission after drug discontinuation. 2. Establish a prediction model of patients with schizophrenia having good prognosis after drug discontinuation.

NCT ID: NCT05667948 Recruiting - Thymic Carcinoma Clinical Trials

Molecular Analysis and Treatment Options of Thymic Malignancies

Start date: January 1, 2016
Phase:
Study type: Observational

Thymic malignancies are the most common tumors of the anterior mediastinum, though surgery and radiation often effectively treat thymic carcinomas, a minority continue to progress and eventually lead to death. Therefore, there is an unmet need for more effective therapies for thymic malignancies. Considering the role of molecular alterations has yet to be defined in the treatment of thymoma and thymic malignancies, there is an urgent recognition that molecular alterations in the thymic malignancies are important to predict response and survival for novel targeted therapies. In summary, identification of genetic alterations in thymic malignancies is increasingly essential to perform molecular diagnostics and individualized treatments. This project aims to create a registry of patients with thymic malignancies to further the characterization of molecular alterations and develop (novel) treatments based on the detection.

NCT ID: NCT05667623 Recruiting - Clinical trials for Atopic Dermatitis (AD)

To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD

Start date: February 6, 2023
Phase: Phase 3
Study type: Interventional

This is a multinational (China and Korea), multicenter, randomized, double-blind, vehicle-controlled, parallel-group, comparison trial to demonstrate the superiority of 1% OPA-15406 ointment to the vehicle in adult AD subjects.

NCT ID: NCT05667506 Recruiting - Clinical trials for B-cell Acute Lymphoblastic Leukemia

A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)

Start date: February 7, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This is a multi-center, phase Ib/II trial to evaluate the safety and efficacy of CNCT19 treatment in Children and Adolescent (pediatric) patients with relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-cell ALL).

NCT ID: NCT05667363 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Digital Therapeutics on Inhalation Medication Adherence in COPD

Start date: December 20, 2022
Phase: N/A
Study type: Interventional

Digital Therapeutics (DTx) is an evidence-based,clinically evaluated software to treat,manage,and prevent a broad spectrum of diseases and disorders according to Digital Therapeutics Alliance,which may improve the adherence of patients with chronic obstructive pulmonary disease (COPD) to use inhaled medication and reduce the risk of acute exacerbation. This study plans to carry out a randomized controlled trial (RCT), using digital therapy to record and manage the behavior data of patients with COPD in the process of using inhaler medication, and analyze the correlation between digital therapy of COPD and patients' drug compliance and treatment effect.

NCT ID: NCT05667350 Recruiting - Clinical trials for Biliary Tract Cancer

AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Biliary Tract Cancer (ASCEND-BTC)

Start date: February 28, 2022
Phase:
Study type: Observational

ASCEND-BTC is a prospective, multi-center, observational study aimed at detecting early biliary tract cancer by combined assays of serum protein and cell-free DNA (cfDNA) methylation. The study will enroll approximately 492 participants diagnosed with biliary tract cancer and benign diseases.

NCT ID: NCT05667272 Recruiting - Clinical trials for Postoperative Pancreatic Fistula

A Study on the Occurrence Time of Grade-B Pancreatic Fistula After Pancreatoduodenectomy

Start date: February 1, 2023
Phase:
Study type: Observational

To confirm the time point of CR-POPF of grade-B that patients with biochemical leak after PD or LPD turned into.

NCT ID: NCT05667220 Recruiting - Type 2 Diabetes Clinical Trials

Sitagliptin in Combination With Beidougen Capsule for Type 2 Diabetes

Start date: December 1, 2022
Phase: Phase 4
Study type: Interventional

The study was an interventional non-randomized controlled study and was divided into a Sitagliptin monotherapy (100 mg Qd) group and a Sitagliptin (100mg Qd)+Beidougen capsule (60mg Tid) combination treatment group for one week.

NCT ID: NCT05667194 Recruiting - Clinical trials for Advanced Solid Tumors

Phase 1 Trial of KH617

Start date: December 26, 2022
Phase: Phase 1
Study type: Interventional

KH617 is a injection used for advanced solid tumors which must be diluted with 5% Dextrose Injection.